Dr. Sulaiman Al Habib Medical Services Group Company EBIT

The latest EBIT for 4013.SR is $2.8B as of June 2026. That compares with $2.7B in the prior-year period — up 2.6% year over year. That is above the sector sector average of $-25M. Investors often review this figure alongside Dr. Sulaiman Al Habib Medical Services Group Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4013.SR's EBIT moved from $2.7B to $2.8B — a 2.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dr. Sulaiman Al Habib Medical Services Group Company's operating scale or balance-sheet position.

Against its sector companies, 4013.SR currently prints $2.8B for EBIT, while the sector average sits near $-25M. That is roughly 11208.5% above the sector mean. Large gaps often invite a closer look at Dr. Sulaiman Al Habib Medical Services Group Company's growth, margins, and balance sheet.

A EBIT figure of $2.8B for 4013.SR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.

After noting 4013.SR's EBIT ($2.8B), review year-over-year change from $2.7B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.